NCT00043680View on ClinicalTrials.gov

Celecoxib to Treat Macular Degeneration in Patients Receiving Photodynamic Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 31, 2002

Study Completion Date

January 31, 2005

Conditions
Macular Degeneration
Interventions
DRUG

Celecoxib

Trial Locations (1)

20892

National Eye Institute (NEI), Bethesda

All Listed Sponsors
lead

National Eye Institute (NEI)

NIH

NCT00043680 - Celecoxib to Treat Macular Degeneration in Patients Receiving Photodynamic Therapy | Biotech Hunter | Biotech Hunter